Drug Type Small molecule drug |
Synonyms- |
Action degraders |
Mechanism AR degraders(Androgen Receptor degraders), GSPT1 degraders(G1 to S phase transition 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | - | 28 Jan 2025 | |
Alzheimer Disease | Discovery | - | 28 Jan 2025 | |
Alzheimer Disease | Discovery | - | 28 Jan 2025 | |
Cardiovascular Diseases | Discovery | - | 28 Jan 2025 | |
Cardiovascular Diseases | Discovery | - | 28 Jan 2025 | |
Cardiovascular Diseases | Discovery | - | 28 Jan 2025 | |
Endocrinology and Metabolic Disease | Discovery | - | 28 Jan 2025 | |
Neoplasms | Discovery | - | 28 Jan 2025 | |
Neoplasms | Discovery | - | 28 Jan 2025 | |
Neoplasms | Discovery | - | 28 Jan 2025 |